On May 12, 2020, Medifron DBT Co., Ltd. (KOSDAQ:A065650) closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3,985 KRW | +1.79% | -9.43% | -19.49% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
3,005 KRW | -3.22% | +13.40% | 109M | ||
1,452 KRW | -2.75% | +1.26% | 88.16M | ||
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-19.49% | 164M | |
+12.50% | 68.79B | |
+7.35% | 17.45B | |
+20.68% | 13.58B | |
+8.66% | 13.35B | |
+12.48% | 9.8B | |
-20.94% | 6.74B | |
-4.74% | 5.95B | |
+2.67% | 5.23B | |
-3.21% | 4.85B |
- Stock Market
- Equities
- A204620 Stock
- News Global Tax Free Co., Ltd.
- Medifron DBT Co., Ltd. announced that it has received KRW 8.09999552 billion in funding from Brain Contents CO., LTD., Global Tax Free Co., Ltd., and other investors